Yang Li | Medicine | Best Researcher Award

Posted on by sciencefather

Dr. Yang Li | Medicine | Best Researcher Award

Shanghai East Hospital, Tongji University School of Medicine | China

Dr. Yang Li is a dedicated postdoctoral researcher at Shanghai East Hospital, affiliated with the Tongji University School of Medicine. With a strong background in internal medicine, he has actively contributed to medical research and patient care. His academic journey is marked by significant achievements, and his work continues to impact the field of clinical medicine, particularly in the areas of metabolic disorders and geriatric health.

Professional profile👤

ORCID

Scopus

Strengths for the Awards✨

  • Strong Academic Background

    • Yang Li has a well-structured academic trajectory, progressing from a Bachelor’s degree in Clinical Medicine to a Postdoctoral position at a reputable institution (Shanghai East Hospital, Tongji University School of Medicine).

    • The M.D. in Internal Medicine and a prior Master’s degree provide a solid foundation for research in this field.

  • Impressive Publication Record

    • Multiple first-author publications in well-regarded medical journals, indicating independent research contributions.

    • Publications focus on crucial areas such as metabolic diseases, multimorbidity, and nephroprotection, showcasing a diverse yet specialized research profile.

    • Collaboration with multidisciplinary teams suggests strong teamwork and networking in the research community.

  • Impactful Research Topics

    • The studies address real-world clinical challenges, including lipid metabolism, diabetes, multimorbidity, and nephroprotection, which have significant implications for patient care.

    • The use of large-scale datasets and real-world analysis enhances the credibility and applicability of findings.

  • Consistency and Productivity

    • Continuous output of publications from 2022 to 2025 demonstrates a sustained research commitment.

    • The ability to conduct retrospective cohort studies and cross-sectional analyses highlights strong methodological expertise.

Education 🎓

Yang Li pursued his higher education at Tongji University, where he earned multiple degrees in clinical and internal medicine:

  • M.D. in Internal Medicine (2020-2023)
  • Master’s Degree in Internal Medicine (2017-2019)
  • Bachelor’s Degree in Clinical Medicine (2011-2017) His academic training has equipped him with in-depth knowledge and expertise in diagnosing and treating complex medical conditions.

Experience 🎉

As a postdoctoral researcher at Shanghai East Hospital, Yang Li has been deeply involved in clinical research, focusing on metabolic health, multimorbidity, and geriatric care. His work bridges the gap between clinical practice and research, aiming to improve patient outcomes through evidence-based findings. His experience spans retrospective cohort studies, cross-sectional analyses, and real-world population-based research.

Research Interest On Medicine 🔬

Yang Li’s research interests include:

  • Metabolic Disorders & Insulin Resistance
  • Geriatric Multimorbidity and Critical Care
  • Cardiometabolic Health & Lifestyle Factors
  • Pharmacological Interventions in Diabetes Management Through his research, he seeks to understand the intricate relationships between metabolic health, aging, and disease prevention.

Awards 🏆

Yang Li has received recognition for his significant contributions to medical research. His work has been acknowledged in the form of grants, academic awards, and invitations to present at international conferences. His research excellence continues to earn him accolades in the scientific community.

Publications 📚

Yang Li has authored multiple impactful publications in peer-reviewed journals. Some of his notable works include:

  • “Sex differences in associations of metabolic inflammation and insulin resistance with incident type 2 diabetes mellitus: a retrospective cohort of adults with annual health examinations”

    • Authors: Yang Li, Xiaotong Guo, Jianli Ge, Qingqing Li, Xin Chen, Yingqian Zhu, Huixiao Yuan, Shasha Geng, Yue Liu​

    • Publication Year: 2025​

  • “Multimorbidity in elderly patients with or without T2DM: A real-world cross-sectional analysis based on primary care and hospitalisation data”

    • Authors: Yang Li, Shasha Geng, Huixiao Yuan, Jianli Ge, Qingqing Li, Xin Chen, Yingqian Zhu, Yue Liu, Xiaotong Guo, Xiaoli Wang, et al.​

    • Publication Year: 2024​

  • “Nephroprotective effect of SGLT2 inhibitors in elderly patients with type 2 diabetes mellitus and hypertension: a real-world population-based cohort study”

    • Authors: Shasha Geng, Yang Li, Jianli Ge, Yue Liu, Qingqing Li, Xin Chen, Yingqian Zhu, Xiaotong Guo, Huixiao Yuan, Xiaoli Wang, et al.​

    • Publication Date: November 16, 2024​

  • “Global trends in research related to functional dyspepsia and anxiety or depression over the past two decades: a bibliometric analysis”

    • Authors: Qian Huang, Huixiao Yuan, Qingqing Li, Yang Li, Shasha Geng, Yingqian Zhu, Min Liao, Hua Jiang​

    • Publication Year: 2023​

  • “Identification of the cuproptosis-related hub genes and therapeutic agents for sarcopenia”

    • Authors: Yingqian Zhu, Xin Chen, Shasha Geng, Qingqing Li, Yang Li, Huixiao Yuan, Hua Jiang​

    • Publication Year: 2023​

  • “Reliability of Risk Assessment for Intra-Hospital Venous Thromboembolism: An Exploratory Cross-Sectional Study”

    • Authors: Shasha Geng, Yang Li, Jianli Ge, Xiaotong Guo, Yue Liu, Hua Jiang​

    • Publication Year: 2023​

  • “Lifestyle-based oxidative balance score and its association with cardiometabolic health of the community-dwelling elderly: A cross-sectional secondary analysis”

    • Authors: Yang Li, Huixiao Yuan, Qingqing Li, Shasha Geng, Xin Chen, Yingqian Zhu, Hua Jiang​

    • Publication Date: September 27, 2022​

  • “Circular RNA expression profiles in extracellular vesicles from the plasma of patients with pancreatic ductal adenocarcinoma”

    • Authors: Yang Li, Qingqing Li, Huixiao Yuan, Shasha Geng, Xin Chen, Yingqian Zhu, Hua Jiang​

    • Publication Date: December 2019​

  • “Using the Risk Factors of Pancreatic Cancer and Their Interactions in Cancer Screening: A Case-Control Study in Shanghai, China”

    • Authors: Yang Li, Qingqing Li, Huixiao Yuan, Shasha Geng, Xin Chen, Yingqian Zhu, Hua Jiang​

    • Publication Date: July 11, 2019​

Conclusion 🏅

Yang Li is an accomplished medical researcher whose work contributes significantly to the field of internal medicine. His dedication to advancing medical knowledge, combined with his expertise in metabolic and geriatric health, underscores his role as a leading researcher in his field. Through his publications and ongoing research, he continues to impact patient care and medical science positively.

Haotai Xie | Medicine | Best Researcher Award

Posted on by sciencefather

Dr. Haotai Xie | Medicine | Best Researcher Award

Peking University First Hospital | China

Dr. Haotai Xie is a dedicated clinician and researcher at Peking University First Hospital, specializing in cardiovascular diseases and bioinformatics. With a passion for advancing precision cardiology, Dr. Xie integrates computational approaches into clinical practice, enhancing diagnostic accuracy and therapeutic strategies. His work spans biomarker discovery, algorithm development, and non-invasive myocardial ischemia evaluation. Dr. Xie has authored seven first-author SCI papers in high-impact journals, contributing significantly to cardiovascular medicine and epigenetics.

Professional profile👤

ORCID

Scopus

Strengths for the Awards✨

  • Academic Productivity: Published seven first-author SCI papers in prestigious journals like Nucleic Acids Research, Briefings in Bioinformatics, and JAHA, accumulating a total impact factor exceeding 40.
  • Innovative Research: Co-developed PhaSepDB and MloDisDB, which have become cornerstone resources in phase separation research, cited in over 50 studies.
  • Interdisciplinary Expertise: Bridges cardiovascular medicine and bioinformatics, applying computational methods to improve diagnostic tools and biomarker discovery, enhancing precision cardiology.
  • Significant Contributions: Pioneered the characterization of cardiovascular phenotypes in Kleefstra syndrome, leading to evidence-based screening protocols, with direct implications for clinical guidelines and rare disease management.
  • Research Impact: Work has advanced the understanding of cardiovascular epigenetics and contributed to earlier diagnosis and more personalized treatment strategies.

🎓 Education

  • Doctorate in Clinical Medicine, Peking University First Hospital, China.

💼 Experience

  • Doctor, Peking University First Hospital.
  • Lead researcher in interdisciplinary projects bridging computational biology and cardiovascular medicine.
  • Co-developed PhaSepDB and MloDisDB, pivotal resources for phase separation research.

🔬 Research Interests On Medicine

  • Cardiovascular Medicine
  • Bioinformatics
  • Precision Cardiology
  • Biomarker Discovery
  • AI-driven Diagnostic Tools

🏆 Awards

  • Recognized for sustained academic productivity and innovation in cardiovascular research.

📓 Publications

  • “Association between urinary sodium excretion and all-cause mortality: a cohort study in a Chinese community-based population”

    • Year: 2025
    • Authors: Haotai Xie, Xinyan Wen, Fangfang Fan, Jia Jia, Yong Huo, Yanjun Gong, Yan Zhang
    • Citations: Not available yet (published recently)

  • “Highlighting cardiovascular manifestations of Kleefstra syndrome: literature review and clinical insights”

    • Year: 2025
    • Authors: Haotai Xie, Pengkang He, Qinhui Sheng, Wei Ma, Yanjun Gong, Yan Zhang, Lin Qiu
    • Citations: Not available yet (published recently)

  • “Rethinking the Functional SYNTAX Score Threshold”

    • Year: 2024
    • Authors: Haotai Xie
    • Citations: Not available yet (upcoming publication)

  • “Research Progress and Clinical Value of Subendocardial Viability Ratio”

    • Year: 2024
    • Authors: Haotai Xie, Lan Gao, Fangfang Fan, Yanjun Gong, Yan Zhang
    • Citations: Not available yet (recent publication)

  • “PhaSepDB in 2022: annotating phase separation-related proteins with droplet states, co-phase separation partners and other experimental information”

    • Year: 2023
    • Authors: Chao Hou, Xinxin Wang, Haotai Xie, Taoyu Chen, Peiyu Zhu, Xiaofeng Xu, Kaiqiang You, Tingting Li
    • Citations: Not specified

  • “Application of B-Type Natriuretic Peptide in Neonatal Diseases”

    • Year: 2021
    • Authors: Haotai Xie, Yixuan Huo, Qinzheng Chen, Xinlin Hou
    • Citations: Not specified

  • “MloDisDB: a manually curated database of the relations between membraneless organelles and diseases”

    • Year: 2021
    • Authors: Chao Hou, Haotai Xie, Yang Fu, Yao Ma, Tingting Li
    • Citations: Not specified

🔔 Conclusion

Dr. Haotai Xie exemplifies the fusion of clinical expertise and computational innovation, driving advancements in cardiovascular medicine. His research has not only deepened the understanding of cardiovascular diseases but also paved the way for precision cardiology. With a robust publication record and interdisciplinary approach, Dr. Xie continues to shape the future of cardiovascular health management through groundbreaking discoveries and technological integration.

Gregory Redding | Medicine | Best Researcher Award

Posted on by sciencefather

Dr. Gregory Redding | Medicine | Best Researcher Award

Professor of Pediatrics | University of Washington School of Medicine | United States

Dr. Gregory J. Redding, MD, is a distinguished pediatric pulmonologist known for his extensive contributions to pediatric respiratory medicine. Born on December 8, 1948, in Patuxent River, Maryland, he has dedicated his career to advancing pulmonary care, education, and research. With over four decades of experience, Dr. Redding has held prominent academic and clinical positions, shaping the field with his expertise and leadership. His dedication to patient care, innovative research, and mentorship has earned him numerous accolades throughout his career.

Profile👤

ORCID

Scopus

Strengths for the Awards✨

✅ Extensive Experience: Dr. Redding has had a distinguished career spanning over four decades in pediatric pulmonology and sleep medicine, holding leadership roles at the University of Washington School of Medicine and Seattle Children’s Hospital.

✅ Research Contributions: His tenure includes multiple fellowships, faculty positions, and research leadership roles, with significant contributions to asthma, cystic fibrosis, and pediatric respiratory medicine.

✅ Recognition & Awards: He has been consistently recognized as a Top Doctor (2000-2025) and has received prestigious awards such as:

  • Lifetime Contributions to Pediatric Respiratory Medicine Award (2019, ATS)
  • Edwin L. Kendig, Jr Lifetime Achievement Award (2015, AAP)
  • Pulmonary Hall of Fame Award (2001, ALA of Washington)

✅ Leadership & Professional Impact: He has chaired or served on numerous committees in national and international respiratory and pediatric societies, influencing clinical practice and policy development.

🎓 Education:

Dr. Redding’s academic journey began with a Bachelor of Arts (B.A.) from the University of California, San Diego, in 1970. He then pursued his Doctor of Medicine (M.D.) degree at Stanford University School of Medicine, graduating in 1974. Following medical school, he completed an internship (1974-75) and pediatric residency (1975-77) at Harbor General Hospital in Torrance, California. Further specializing in pediatric pulmonology, he underwent fellowship training at the University of Colorado Medical Center from 1977 to 1979, followed by a postdoctoral research fellowship in the Cardiovascular Pulmonary Research Laboratory (1979-80).

💼 Experience:

Dr. Redding has had a prolific career in both academia and clinical practice. He has been a faculty member at the University of Washington School of Medicine since 1980, progressing through the ranks from Assistant Professor to full Professor in the Department of Pediatrics. His leadership roles at Seattle Children’s Hospital have been pivotal, where he served as Chief of the Pulmonary and Sleep Medicine Division (2010-2023) and Chief of the Pediatric Pulmonary Division (1980-2010). In addition, he has held consulting medical staff positions at renowned institutions, including Seattle Cancer Care Alliance, Alaska Native Medical Center, and Harborview Medical Center.

🔬 Research Interests On Medicine

Dr. Redding’s research focuses on pediatric respiratory disorders, including cystic fibrosis, asthma, and pulmonary function in children with craniofacial anomalies. He has been actively involved in clinical and translational research, contributing to the advancement of pediatric pulmonology through his investigations into airway inflammation, bronchiolitis management, and the long-term effects of respiratory conditions. His commitment to improving pediatric respiratory care has led to influential studies and practice-changing guidelines.

🏆 Awards & Honors:

Throughout his career, Dr. Redding has received numerous prestigious awards recognizing his contributions to pediatric pulmonology. He has been consistently listed among America’s Top Doctors (2001-2023) and Seattle’s Top Doctors (2002-2025). Notable accolades include the American Thoracic Society Assembly on Pediatrics Lifetime Contributions to Pediatric Respiratory Medicine Award (2019), the Edwin L. Kendig, Jr. Lifetime Achievement Award for Pediatric Pulmonology (2015), and the Robert M. Campbell, Jr. Award for Innovation in Early Onset Scoliosis (2018). His commitment to teaching has been recognized with multiple Pediatric Housestaff Awards for Outstanding Teaching at Seattle Children’s Hospital.

📚 Publications:

Dr. Redding has authored numerous peer-reviewed publications in leading medical journals. His research has been widely cited, influencing clinical practice and pediatric pulmonology guidelines. Some of his key publications include:

  • “Changes in Diaphragm Intrusion and Thoracic Dimensions After Posterior Spinal Fusion in Patients With Neuromuscular Scoliosis”

    • Authors: G.A. Benes, Gregory A.; P.G. Gabos, Peter G.; G.J. Redding, Gregory J.; P.J. Cahill, Patrick J.; P.D. Sponseller, Paul David
    • Publication Year: 2025

  • “Posterior Column Release and Lengthening with a Magnetic Growing Rod Construct in Severe Congenital Thoracic Fusion: A Report of 2 Cases”

    • Authors: M. Trask, Michael; J.T. Yamaguchi, Jonathan Tad; G.J. Redding, Gregory J.; S.R. Browd, Samuel R.; K.K. White, Klane K.
    • Publication Year: 2024

  • “In-office Maximal Voluntary Ventilation Testing Demonstrates Pulmonary Improvement Following Posterior Spinal Fusion for Adolescent Idiopathic Scoliosis”

    • Authors: H.B. Jalloh, Hulaimatu B.; L.M. Andras, Lindsay M.; G.J. Redding, Gregory J.; J. Yang, Joshua; D.L. Skaggs, David L.
    • Publication Year: 2024

  • “Elevated Periodic Limb Movement Index is Associated with Hypoxemia in Children with Early Onset Scoliosis”

    • Authors: L.M. DelRosso, Lourdes M.; D. Panek, David; E.W. MacKintosh, Erin Walker; K.K. White, Klane K.; G.J. Redding, Gregory J.
    • Publication Year: 2024

  • “Pre-op Considerations in Neuromuscular Scoliosis Deformity Surgery: Proceedings of the Half Day Course at the 58th Annual Meeting of the Scoliosis Research Society”

    • Authors: M.C. Welborn, Michelle Cameron; G.J. Redding, Gregory J.; P.D. Evers, Patrick D.; S.C. Poon, Selina C.; S.W. Hwang, Steven W.
    • Publication Year: 2024

  • “Chronic Respiratory Disease in Indigenous Peoples: A Framework to Address Inequity and Strengthen Respiratory Health and Health Care Globally”

    • Authors: A.B. Chang, Anne B.; T.A. Kovesi, Thomas Andrew; G.J. Redding, Gregory J.; P.J. Torzillo, Paul John; D.M. Gray, Diane M.
    • Publication Year: 2024
    • Citations: 8

  • “Paediatric Syndromic Scoliosis: Proceedings of the Half-Day Course at the 57th Annual Meeting of the Scoliosis Research Society”

    • Authors: J.S. Mehta, Jwalant S.; J.M. Pahys, Joshua M.; A.I. Saad, Ahmed Isam; M.C. Welborn, Michelle Cameron; G.J. Redding, Gregory J.
    • Publication Year: 2024
    • Citations: 2

  • “Social Determinants of Respiratory Health from Birth: Still of Concern in the 21st Century?”

    • Authors: A.P. Bush, Andrew P.; C.A. Byrnes, C. A.; K.C.C. Chan, Kate Ching Ching; I.P. Sinha, Ian P.; H.J. Zar, Heather J.
    • Publication Year: 2024
    • Citations: 8

  • “Chest and Spinal Disease in Patients with Progressive Neuromuscular Disease”

    • Authors: O.H. Mayer, Oscar Henry; G.J. Redding, Gregory J.
    • Publication Year: 2024
    • Citations: 0

  • “Preoperative Left Shoulder Elevation > 1 cm is Predictive of Severe Postoperative Shoulder Imbalance in Early Onset Idiopathic Scoliosis Patients Treated with Growth-Friendly Instrumentation”

    • Authors: Y. Li, Ying; D.Z. Yang, Daniel Z.; R. Bergman, Rachel; Y. Li, Ying; C.R. Louer, Craig R.
    • Publication Year: 2023
    • Citations: 1

🔚 Conclusion:

Dr. Gregory J. Redding, MD, stands as a pillar in pediatric pulmonology, contributing significantly to patient care, research, and medical education. His lifelong commitment to improving respiratory health in children has left a lasting impact on the field. Through his academic leadership, clinical expertise, and dedication to mentoring the next generation of pediatric pulmonologists, Dr. Redding continues to shape the future of pediatric respiratory medicine. His work remains a testament to excellence in medicine, research, and advocacy for pediatric respiratory health.

Youngji Jo | Medicine | Best Researcher Award

Posted on by sciencefather

Dr. Youngji Jo | Medicine | Best Researcher Award

Assistant Professor | UConn Health | United States

Dr. Youngji Jo is an esteemed researcher and academic with a profound background in public health sciences, epidemiology, and health systems modeling. She currently serves as an Assistant Professor in the Department of Public Health Science at the University of Connecticut (UConn Health), USA. With a wealth of experience in infectious disease modeling, health economics, and digital health, Dr. Jo has made significant contributions to global health research, particularly in tuberculosis (TB), HIV, and COVID-19 studies. Her interdisciplinary expertise bridges epidemiology, policy evaluation, and data-driven decision-making.

Profile👤

ORCID

Scopus

Google Scholar

Strengths for the Awards✨

✅ Outstanding Research Contributions: Dr. Youngji Jo has an extensive research portfolio, with expertise in epidemiology, infectious disease modeling, digital health, and public health interventions. She has made significant contributions to tuberculosis (TB) and HIV/AIDS research, as well as COVID-19 modeling, demonstrating her impact on global health policy and disease control.

✅ Strong Funding and Grant Record: She has secured multiple prestigious grants, including from the NIH (F32 Fellowship), Bill & Melinda Gates Foundation, and Korea Disease Control and Prevention Agency. Her ability to attract competitive funding highlights the recognition of her work in the scientific community.

✅ Interdisciplinary and Global Research Impact: Her work spans multiple countries, including the U.S., South Korea, India, Bangladesh, and Nigeria. She has collaborated with top institutions such as Johns Hopkins University, Boston Medical Center, Korea University, and the WHO, indicating a strong global research network.

✅ Applied and Policy-Relevant Research: Her projects focus on real-world impact, such as cost-effectiveness of public health interventions, mathematical modeling of infectious diseases, and policy development for pandemics. This makes her research highly relevant to public health decision-making.

✅ Recognition and Awards: She has received several competitive scholarships and fellowships, such as the NIH Fellowship, WHO-JHU Global mHealth Initiative Scholarship, and conference awards from the International AIDS Society and CROI, reflecting her academic excellence.

Education 🎓

Dr. Jo earned her Ph.D. in Health Systems from the International Health Department at Johns Hopkins Bloomberg School of Public Health, USA. Her doctoral dissertation focused on the cost-effectiveness and scalability of an mHealth intervention to improve pregnancy surveillance in rural Bangladesh. She further enhanced her expertise with post-doctoral fellowships at Boston Medical Center and Johns Hopkins Bloomberg School of Public Health, specializing in infectious disease modeling and health systems research. She holds an M.A. in International Economics & International Relations from Johns Hopkins School of Advanced International Studies (SAIS) and a B.E. in Electrical Engineering from Seoul National University, South Korea.

Experience 💼

Dr. Jo’s extensive research career includes roles as a Post-Doctoral Fellow at Boston University, where she investigated the intersection of HIV and TB care delivery. She has served as a Research Scientist at the Bill & Melinda Gates Foundation, developing agent-based stochastic TB models. Additionally, she has collaborated with global institutions such as the Korea Disease Control and Prevention Agency, RIGHT Foundation, and WHO, contributing to the development of health technologies, pandemic policy evaluations, and mathematical modeling for infectious diseases.

Research Interests On Medicine 📝

Dr. Jo’s research spans multiple critical areas of public health, including:

  • Infectious disease modeling (TB, HIV, COVID-19)
  • Health economics and cost-effectiveness analysis
  • Digital health interventions and mHealth solutions
  • Global health policy evaluation
  • Big data and artificial intelligence applications in epidemiology

Awards & Honors 🏆

Dr. Jo has received numerous accolades for her contributions to public health research, including:

  • Pre-K Junior Faculty Career Development Award (2022-Present)
  • NIH F32 Individual Fellowship Grant (2020-2022)
  • International AIDS Society Conference Scholarship (2021)
  • Gordis Teaching Fellowship at Johns Hopkins University (2014)
  • WHO-JHU Global mHealth Initiative Scholarship (2012)
  • Japan Student Services Organization (JASSO) Government Scholarship (2005-2006)

Publications 📚

Dr. Jo has published extensively in high-impact journals. Some of her recent publications include:

  • Integrated multi‐month dispensing for HIV and hypertension in South Africa: A model of epidemiological impact and cost‐effectiveness

    • Year: 2025
    • Authors: Youngji Jo, Sydney Rosen, Brooke E. Nichols, Lise Jamieson, Nkgomeleng Lekodeba, Robert Horsburgh, Jr.

  • Nationwide Target Trial Emulation Evaluating the Clinical Effectiveness of Oral Antivirals for COVID-19 in Korea

    • Year: 2024
    • Authors: Kyungmin Huh, Youngji Jo, Gi Hwan Bae, Hyejin Joo, Munkhzul Radnaabaatar, Hyungmin Lee, Jungyeon Kim, Dong-Hwi Kim, Min-Gyu Yoo, Il Uk Jo et al.

  • Antenatal care in rural Bangladesh: current state of costs, content and recommendations for effective service delivery

    • Authors: Y Jo, K Alland, H Ali, S Mehra, AE LeFevre, S Pak, S Shaikh, P Christian, …
    • Year: 2019
    • Citations: 62

  • Using the lives saved tool (LiST) to model mHealth impact on neonatal survival in resource-limited settings

    • Authors: Y Jo, AB Labrique, AE Lefevre, G Mehl, T Pfaff, N Walker, IK Friberg
    • Year: 2014
    • Citations: 59

  • Cost-effectiveness of remdesivir and dexamethasone for COVID-19 treatment in South Africa

    • Authors: Y Jo, L Jamieson, I Edoka, L Long, S Silal, JRC Pulliam, H Moultrie, …
    • Year: 2021
    • Citations: 57

  • Drinking and driving in Vietnam: public knowledge, attitudes, and practices

    • Authors: NT Tran, AM Bachani, VC Pham, JC Lunnen, Y Jo, J Passmore, …
    • Year: 2012
    • Citations: 49

  • Model-based cost-effectiveness of state-level latent tuberculosis interventions in California, Florida, New York, and Texas

    • Authors: Y Jo, S Shrestha, I Gomes, S Marks, A Hill, G Asay, D Dowdy
    • Year: 2021
    • Citations: 37

  • Forecasting the value for money of mobile maternal health information messages on improving utilization of maternal and child health services in Gauteng, South Africa: cost …

    • Authors: A LeFevre, MA Cabrera-Escobar, D Mohan, J Eriksen, D Rogers, …
    • Year: 2018
    • Citations: 26

  • Model-based cost-effectiveness analysis of oral antivirals against SARS-CoV-2 in Korea

    • Authors: Y Jo, SB Kim, M Radnaabaatar, K Huh, JH Yoo, KR Peck, H Park, J Jung
    • Year: 2022
    • Citations: 23

  • Costs and cost-effectiveness analyses of mCARE strategies for promoting care seeking of maternal and newborn health services in rural Bangladesh

    • Authors: Y Jo, AE LeFevre, K Healy, N Singh, K Alland, S Mehra, H Ali, S Shaikh, …
    • Year: 2019
    • Citations: 23

Conclusion 🔖

Dr. Youngji Jo is a distinguished academic and researcher whose interdisciplinary expertise continues to shape the landscape of global public health. Her contributions to infectious disease modeling, health economics, and digital health interventions have significantly advanced our understanding of TB, HIV, and COVID-19. As she continues her research at UConn Health, her work remains at the forefront of data-driven solutions for global health challenges.

Alphonse Houssou Hounye | medicine | Best Researcher Award

Posted on by sciencefather

Dr. Alphonse Houssou Hounye | Medicine | Best Researcher Award

Second Xiangya Hospital | Central south university | China

Dr. Hounye Alphonse Houssou is a dedicated mathematician and researcher currently affiliated with the General Surgery Department at the Second Xiangya Hospital, Central South University, China. With a focus on bioinformatics, image processing, and statistical machine learning, Dr. Houssou is recognized for his significant contributions to scientific research, particularly in cancer prognosis and machine learning models.

Profile

Scopus

Orcid

Strengths for the Awards

Dr. Alphonse Hounye Houssou demonstrates exceptional strengths in the field of scientific research, particularly in bioinformatics, image processing, and machine learning. His contributions include:

  1. Extensive Research Output: With 32 research papers and 21 SCI-indexed publications, including eight as the first author, Dr. Houssou has proven his ability to publish high-quality and impactful research.
  2. Innovative Contributions: His work on high-dimensional omics data analysis has led to groundbreaking findings, such as identifying hub immune-related genes (TRIM67, CORT, PSPN, SCAMP5, RFXAP) in pancreatic cancer prognosis.
  3. Recognition and Awards: He has earned multiple prestigious awards, including the ITCIE Award, Best Researcher Award (International Research Awards), and the Outstanding International Student Award (2022–2023).
  4. Leadership and Collaboration: Dr. Houssou has collaborated with over 10 institutions, participated in COVID-19-related research projects, and contributed to academic seminars, showcasing his leadership and teamwork abilities.

Education 🎓

Dr. Hounye Alphonse Houssou obtained a B.S. in Mathematics from Abomey-Calavi University, Benin, and earned an M.S. in Mathematical Statistics from JiangXi University of Finance and Economics, China, in 2015 and 2020, respectively. Currently, he is pursuing a Ph.D. at the School of Mathematics and Statistics, Central South University, China.

Experience 🏢

With extensive academic and professional experience, Dr. Houssou has been part of numerous innovative research projects. He has also contributed to COVID-19-related academic seminars and exhibited leadership across multidisciplinary teams. Additionally, he actively collaborates with over 10 research institutions globally, contributing to groundbreaking scientific advancements.

Research Interests On medicine🔬

Dr. Houssou’s research interests include:

  • Bioinformatics
  • Image Processing
  • Statistical and Deep Machine Learning

His work focuses on analyzing high-dimensional omics data, developing individualized risk assessments, and uncovering disease biomarkers for improved diagnostics and treatments, particularly in oncology.

Awards 🏆

Dr. Houssou has received several prestigious accolades:

  • ITCIE Award for research excellence
  • Best Researcher Award (International Research Award on Advanced Nanomaterials and Nanotechnology)
  • Outstanding International Student Award (2022–2023)

These awards reflect his contributions to advanced scientific research and innovation.

Publications 📚

  • Title: Characterization of PANoptosis-related genes in Crohn’s disease by integrated bioinformatics, machine learning, and experiments
    Authors: Yang, Y., Hounye, A.H., Chen, Y., Shi, G., Xiao, Y.
    Year: 2024
    Citations: 2
  • Title: A graph-optimized deep learning framework for recognition of Barrett’s esophagus and reflux esophagitis
    Authors: Hou, M., Wang, J., Liu, T., Wang, K., Chen, S.
    Year: 2024
    Citations: 0
  • Title: Explainable machine learning model identified potential biomarkers in liver cancer survival prediction
    Authors: Pan, Q., Houssou Hounye, A., Miao, K., Hou, M., Xiong, L.
    Year: 2024
    Citations: 0
  • Title: Automated heart disease prediction using improved explainable learning-based technique
    Authors: Bizimana, P.C., Zhang, Z., Hounye, A.H., Hammad, M., El-Latif, A.A.A.
    Year: 2024
    Citations: 3
  • Title: Explainable cancer factors discovery: Shapley additive explanation for machine learning models demonstrates the best practices in the case of pancreatic cancer
    Authors: Su, L., Hounye, A.H., Pan, Q., Hou, M., Xiong, L.
    Year: 2024
    Citations: 1
  • Title: Exploring explainable machine learning and Shapley additive explanations (SHAP) technique to uncover key factors of HNSC cancer: An analysis of the best practices
    Authors: Miao, K., Houssou Hounye, A., Su, L., Hou, M., Xiong, L.
    Year: 2024
    Citations: 5
  • Title: Integrated explainable machine learning and multi-omics analysis for survival prediction in cancer with immunotherapy response
    Authors: Hounye, A.H., Xiong, L., Hou, M.
    Year: 2024
    Citations: 0
  • Title: SCARNet: using convolution neural network to predict time series with time-varying variance
    Authors: Zhao, S., Kong, M., Li, R., Hou, M., Cao, C.
    Year: 2024
    Citations: 1
  • Title: Modeling SARS coronavirus-2 omicron variant dynamic via novel fractional derivatives with immunization and memory trace effects
    Authors: Liu, T., Yin, X., Liu, Q., Houssou Hounye, A.
    Year: 2024
    Citations: 1
  • Title: Evaluation of drug sensitivity, immunological characteristics, and prognosis in melanoma patients using an endoplasmic reticulum stress-associated signature based on bioinformatics and pan-cancer analysis
    Authors: Hounye, A.H., Hu, B., Wang, Z., Hou, M., Qi, M.
    Year: 2023
    Citations: 0

Conclusion ✅

Dr. Hounye Alphonse Houssou is a dynamic researcher dedicated to advancing machine learning applications in bioinformatics and medical diagnostics. His impactful contributions to cancer prognosis, along with numerous publications and awards, underscore his role as a leading scientist in the field.

Tadeusz Dobosz | Molecular Medicine | Best Researcher Award

Posted on by sciencefather

Prof. Tadeusz Dobosz | Molecular Medicine | Best Researcher Award

Retired | University of Medicine Wroclaw | Poland

Tadeusz Dobosz, is a distinguished medical scientist and forensic geneticist. Married with two children, he has made significant contributions to the fields of molecular biology, medical genetics, and forensic science. A retired professor, Dobosz is known for his expertise in DNA technologies, paternity testing, and seroanthropology. He has authored over 75 publications on the Philadelphia List, 515 additional papers, and oral presentations with a Hirsch Index of 20. Currently, he is focused on developing a Museum of Medicine.

Profile

Scopus

Orcid

Strenghts for the Awards

  1. Extensive Academic and Professional Experience:
    • Over 49 years of professional engagement in biochemistry, molecular biology, forensic genetics, and medical genetics.
    • Progression from Assistant to University Professor and Head of the Molecular Techniques Unit at the Medical University of Wrocław.
    • Leadership roles in establishing and managing research laboratories, including Molecular Medicine, Paternity Testing, Forensic Genetics, and Seroanthropology.
  2. Research Contributions:
    • Authored 75 publications indexed in the Philadelphia List and over 515 additional papers, oral presentations, and posters.
    • Hirsch Index of 20, indicating a significant impact on the scientific community.
    • Expertise in cutting-edge forensic and genetic technologies, including PCR, SNP analysis, and DNA sequencing.
  3. Pioneering Work in Forensic Science and Genetics:
    • Specializes in human remains identification, ancient DNA (aDNA) research, and non-destructive DNA extraction methods.
    • Innovations in seroanthropology and forensic ballistics, including DNA deposits on weapons, cases, and bullets.
    • Contributions to paternity testing and biological trace investigations.
  4. Legacy and Knowledge Sharing:
    • Continuation of professional contributions post-retirement by organizing a Museum of Medicine and Hospital Museum.
    • A mentor and guide to the next generation of researchers in the Molecular Techniques Unit.
  5. Interdisciplinary Research Interests:
    • Combines molecular genetics with medical diagnostics, forensic ballistics, and even museology, showcasing a holistic and diverse approach to science.

Education 🎓

  • 1963: Graduated from Primary School.
  • 1967: Completed High School.
  • 1971: Earned a degree in Biochemistry from the University of Wrocław.
  • 1977: Achieved a Ph.D. in Immunology.
  • 2001: Obtained Habilitation in Medical Genetics.
  • 2007: Awarded the title of University Professor in Medical Science.

Experience 💼

Tadeusz Dobosz’s career spans diverse roles in biochemistry, immunology, and forensic science:

  • 1971-1974: Ph.D. student and Assistant at the Polish Academy of Sciences.
  • 1975: Expert in the Police Laboratory of Criminalistics.
  • 1979: Lecturer at the Medical University, Department of Forensic Medicine, Wrocław.
  • 2002: Senior Lecturer at the Medical University of Wrocław.
  • 2004-2020: Head of the Molecular Techniques Unit, leading four specialized laboratories in Molecular Medicine, Paternity Testing, Forensic Genetics, and Seroanthropology.
  • 2020: Retired and now actively organizes the Museum of Medicine.

Research Interests 🔬

Professor Dobosz specializes in:

  • Forensic genetics and human remains identification.
  • Ancient DNA (aDNA) preparation, repair, and testing.
  • Non-destructive DNA isolation methods from valuable specimens.
  • DNA computing and forensic ballistics (e.g., DNA traces on weapons and bullets).
    Additionally, he has a keen interest in medical diagnostics using PCR and museology in medicine.

Awards and Recognition 🏆

Although specific awards are not listed, Professor Dobosz’s prolific contributions to molecular genetics and forensic science have established him as a leader in his field. His Hirsch Index of 20 underscores the impact of his work in the scientific community.

Publications 📚

  • “PPARs in Clinical Experimental Medicine after 35 Years of Worldwide Scientific Investigations and Medical Experiments”
    • Authors: Skoczyńska, A.; Ołdakowska, M.; Dobosz, A.; Małodobra-Mazur, M.; Dobosz, T.
    • Year: 2024
    • Citations: 1
  • “DNA Content of Various Fluids and Tissues of the Human Body”
    • Authors: Siuta, J.; Dobosz, A.; Kawecki, J.; Dobosz, T.
    • Year: 2024
    • Citations: 2
  • “The hero of American and Polish nations: a molecular look at Thaddeus Kosciuszko’s cause of death suggests a contribution of endocarditis caused by Cutibacterium acnes infection”
    • Authors: Witt, M.; Tokarski, M.; Ziętkiewicz, E.; Jurek, T.; Dobosz, T.
    • Year: 2022
    • Citations: 0
  • “Analysis of polymorphism in 11 STR markers in the European red deer (Cervus elaphus) population in Poland”
    • Authors: Jonkisz, A.; Lebioda, A.; Cierzniak, A.; Dobosz, T.; Małodobra-Mazur, M.
    • Year: 2022
    • Citations: 0
  • “Inheritance vs. infectivity as a mechanism of malady and death of Frederic Chopin”
    • Authors: Witt, M.; Dobosz, T.
    • Year: 2021
    • Citations: 3
  • “Histone modifications influence the insulin-signaling genes and are related to insulin resistance in human adipocytes”
    • Authors: Małodobra-Mazur, M.; Cierzniak, A.; Myszczyszyn, A.; Kaliszewski, K.; Dobosz, T.
    • Year: 2021
    • Citations: 12
  • “PpMolecular Medicinearg hypermethylation as the first epigenetic modification in newly onset insulin resistance in human adipocytes”
    • Authors: Małodobra-Mazur, M.; Cierzniak, A.; Kaliszewski, K.; Dobosz, T.
    • Year: 2021
    • Citations: 15
  • “DNA methylation in adipocytes from visceral and subcutaneous adipose tissue influences insulin-signaling gene expression in obese individuals”
    • Authors: Cierzniak, A.; Pawelka, D.; Kaliszewski, K.; Dobosz, T.; Małodobra-Mazur, M.
    • Year: 2021
    • Citations: 12
  • “Original and generic clopidogrel: A comparison of antiplatelet effects and active metabolite concentrations in patients without polymorphisms in the ABCB1 gene and the allele variants CYPC192 and 3″
    • Authors: Wójcik, T.; Szymkiewicz, P.; Ściborski, K.; Jonkisz, A.; Protasiewicz, M.
    • Year: 2021
    • Citations: 2
  • “Metabolic differences between subcutaneous and visceral adipocytes differentiated with an excess of saturated and monounsaturated fatty acids”
    • Authors: Małodobra-Mazur, M.; Cierzniak, A.; Pawełka, D.; Rudnicki, J.; Dobosz, T.
    • Year: 2020
    • Citations: 27

Conclusion ✨

Tadeusz Dobosz has left an indelible mark on forensic science, molecular biology, and medical genetics. From pioneering DNA sequencing techniques to advancing paternity testing and forensic genetics, his work has significantly impacted these fields. Even in retirement, his passion for medicine and science continues through his dedication to museology, ensuring that future generations benefit from his expertise and vision.